These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 17351104

  • 1. In vitro and in vivo pharmacological characterization of ethyl-4-[trans-4-[((2S)-2-hydroxy-3-[4-hydroxy-3[(methylsulfonyl)amino]-phenoxy]propyl) amino]cyclohexyl]benzoate hydrochloride (SAR150640), a new potent and selective human beta3-adrenoceptor agonist for the treatment of preterm labor.
    Croci T, Cecchi R, Marini P, Rouget C, Viviani N, Germain G, Guagnini F, Fradin Y, Descamps L, Pascal M, Advenier C, Breuiller-Fouché M, Leroy MJ, Bardou M.
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1118-26. PubMed ID: 17351104
    [Abstract] [Full Text] [Related]

  • 2. Molecular and functional characteristics of β3-adrenoceptors in late pregnant mouse uterus: a comparison with β2-adrenoceptors.
    Parida S, Uttam Singh T, Ravi Prakash V, Mishra SK.
    Eur J Pharmacol; 2013 Jan 30; 700(1-3):74-9. PubMed ID: 23219791
    [Abstract] [Full Text] [Related]

  • 3. Comparison of effects of formoterol and BRL 37344 on isolated term-pregnant rat myometrial strips in vitro.
    Yurtcu N, Cetin A, Karadas B, Gonca Imir A, Kaya T, Erselcan T, Bagcivan I, Cetin M.
    Eur J Pharmacol; 2006 Jan 20; 530(3):263-9. PubMed ID: 16388799
    [Abstract] [Full Text] [Related]

  • 4. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
    Haynes JM.
    Eur J Pharmacol; 2007 Sep 10; 570(1-3):18-26. PubMed ID: 17617401
    [Abstract] [Full Text] [Related]

  • 5. Barusiban suppresses oxytocin-induced preterm labour in non-human primates.
    Reinheimer TM.
    BMC Pregnancy Childbirth; 2007 Jun 01; 7 Suppl 1(Suppl 1):S15. PubMed ID: 17570159
    [Abstract] [Full Text] [Related]

  • 6. SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor.
    Serradeil-Le Gal C, Valette G, Foulon L, Germain G, Advenier C, Naline E, Bardou M, Martinolle JP, Pouzet B, Raufaste D, Garcia C, Double-Cazanave E, Pauly M, Pascal M, Barbier A, Scatton B, Maffrand JP, Le Fur G.
    J Pharmacol Exp Ther; 2004 Apr 01; 309(1):414-24. PubMed ID: 14722330
    [Abstract] [Full Text] [Related]

  • 7. The effects and selectivity of beta-adrenoceptor agonists in rat myometrium and urinary bladder.
    Clouse AK, Riedel E, Hieble JP, Westfall TD.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):184-9. PubMed ID: 17632099
    [Abstract] [Full Text] [Related]

  • 8. Functional coupling of beta3-adrenoceptors and large conductance calcium-activated potassium channels in human uterine myocytes.
    Doheny HC, Lynch CM, Smith TJ, Morrison JJ.
    J Clin Endocrinol Metab; 2005 Oct 14; 90(10):5786-96. PubMed ID: 16014404
    [Abstract] [Full Text] [Related]

  • 9. Effect of oxytocin receptor and beta2-adrenoceptor blockade on myometrial oxytocin receptors in parturient rats.
    Engstrøm T, Bratholm P, Vilhardt H, Christensen NJ.
    Biol Reprod; 1999 Feb 14; 60(2):322-9. PubMed ID: 9915997
    [Abstract] [Full Text] [Related]

  • 10. The combination tocolytic effect of magnesium sulfate and an oxytocin receptor antagonist in myometrium from singleton and twin pregnancies.
    Arrowsmith S, Neilson J, Wray S.
    Am J Obstet Gynecol; 2016 Dec 14; 215(6):789.e1-789.e9. PubMed ID: 27555315
    [Abstract] [Full Text] [Related]

  • 11. SAR150640, a selective beta3-adrenoceptor agonist, prevents human myometrial remodelling and activation of matrix metalloproteinase in an in vitro model of chorioamnionitis.
    Lirussi F, O'Brien M, Wendremaire M, Goirand F, Sagot P, Dumas M, Morrison JJ, Bardou M.
    Br J Pharmacol; 2010 Mar 14; 159(6):1354-66. PubMed ID: 20136828
    [Abstract] [Full Text] [Related]

  • 12. The beta3-adrenoceptor agonist 4-[[(Hexylamino)carbonyl]amino]-N-[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]-phenyl]-benzenesulfonamide (L755507) and antagonist (S)-N-[4-[2-[[3-[3-(acetamidomethyl)phenoxy]-2-hydroxypropyl]amino]-ethyl]phenyl]benzenesulfonamide (L748337) activate different signaling pathways in Chinese hamster ovary-K1 cells stably expressing the human beta3-adrenoceptor.
    Sato M, Hutchinson DS, Evans BA, Summers RJ.
    Mol Pharmacol; 2008 Nov 14; 74(5):1417-28. PubMed ID: 18684840
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effect of barusiban and atosiban on oxytocin-induced contractions of myometrium from preterm and term pregnant women.
    Pierzynski P, Lemancewicz A, Reinheimer T, Akerlund M, Laudanski T.
    J Soc Gynecol Investig; 2004 Sep 14; 11(6):384-7. PubMed ID: 15350251
    [Abstract] [Full Text] [Related]

  • 14. Barusiban, a new highly potent and long-acting oxytocin antagonist: pharmacokinetic and pharmacodynamic comparison with atosiban in a cynomolgus monkey model of preterm labor.
    Reinheimer TM, Bee WH, Resendez JC, Meyer JK, Haluska GJ, Chellman GJ.
    J Clin Endocrinol Metab; 2005 Apr 14; 90(4):2275-81. PubMed ID: 15671092
    [Abstract] [Full Text] [Related]

  • 15. Effect of (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function.
    Takasu T, Ukai M, Sato S, Matsui T, Nagase I, Maruyama T, Sasamata M, Miyata K, Uchida H, Yamaguchi O.
    J Pharmacol Exp Ther; 2007 May 14; 321(2):642-7. PubMed ID: 17293563
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effect of beta3-adrenoceptor agonist in lower esophageal sphincter smooth muscle: in vitro studies.
    Sarma DN, Banwait K, Basak A, DiMarino AJ, Rattan S.
    J Pharmacol Exp Ther; 2003 Jan 14; 304(1):48-55. PubMed ID: 12490574
    [Abstract] [Full Text] [Related]

  • 17. Is the beta3-adrenoceptor (ADRB3) a potential target for uterorelaxant drugs?
    Bardou M, Rouget C, Breuiller-Fouché M, Loustalot C, Naline E, Sagot P, Frydman R, Morcillo EJ, Advenier C, Leroy MJ, Morrison JJ.
    BMC Pregnancy Childbirth; 2007 Jun 01; 7 Suppl 1(Suppl 1):S14. PubMed ID: 17570158
    [Abstract] [Full Text] [Related]

  • 18. Functional, biochemical and molecular biological evidence for a possible beta(3)-adrenoceptor in human near-term myometrium.
    Bardou M, Loustalot C, Cortijo J, Simon B, Naline E, Dumas M, Esteve S, Croci T, Chalon P, Frydman R, Sagot P, Manara L, Morcillo EJ, Advenier C.
    Br J Pharmacol; 2000 Aug 01; 130(8):1960-6. PubMed ID: 10952688
    [Abstract] [Full Text] [Related]

  • 19. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE, Cavero I, Manoury P, Lefevre-Borg F, Langer SZ.
    J Pharmacol Exp Ther; 1987 Sep 01; 242(3):1025-34. PubMed ID: 2888869
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
    Ahmed M, Hanaoka Y, Kiso T, Kakita T, Ohtsubo Y, Muramatsu I, Nagatomo T.
    J Pharm Pharmacol; 2005 Jan 01; 57(1):75-81. PubMed ID: 15638996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.